Bahrain vs Kyrgyzstan: The number of people with susceptibility test result for rifampicin
Bahrain
94.12
in 2021
Kyrgyzstan
94.01
in 2021
Bahrain rank
54th
Kyrgyzstan rank
56th
The number of people with susceptibility test result for rifampicin over time
- Bahrain
- Kyrgyzstan
How they compare
Bahrain currently reports 94.12 against 94.01 in Kyrgyzstan, a difference of 0.11.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bahrain ahead.
Bahrain ranks 54th and Kyrgyzstan ranks 56th of 146 countries.
Across the 2 decades both report, Bahrain averaged higher in 1 and Kyrgyzstan in 1.
Head to head by decade
| Decade | Bahrain | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.36 | 89.91 | 7.45 | Bahrain |
| 2020s | 86.48 | 93.02 | 6.53 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahrain or Kyrgyzstan?
- Bahrain, at 94.12 against 94.01 in Kyrgyzstan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahrain and Kyrgyzstan?
- 0.11, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Kyrgyzstan?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahrain and Kyrgyzstan rank globally for the number of people with susceptibility test result for rifampicin?
- Bahrain ranks 54th and Kyrgyzstan ranks 56th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.